The study, published in the journal Frontiers in Public Health, may help patients seek care promptly or decide to self-isolate sooner
Antibodies found in natural controllers, mutation in virus structure can help control Hepatitis B, studies show
According to the World Health Organisation (WHO), more than 250 million people worldwide are suffering from hepatitis B.
Russia's vaccine is not part of WHO's list of nine COVID-19 candidates in advanced stages of testing
A senior advisor said they are talking to Russia to get more information on the vaccine, trials, what are the next steps.
Tedros said vaccine development is complex, risky and expensive and different types are needed in order to identify the best vaccine candidate.
Russia 'Sputnik V' vaccine promises to help people develop immunity against COVID-19 for two years: Here's all you need to know
Sputnik V can only be used on people within the age groups of 18-60 as more studies need to ensure the vaccine is safe for older people.
The extent of the spread of unreliable information is so great that the COVID-19 pandemic is also being referred to as a ‘disinfodemic’ by the UNESCO
India has voiced the need to invest in primary healthcare but the budget hasn't kept pace with the announcements, experts say.
The vaccine is given in two doses and will help people develop immunity to the virus for at least two years.
Infectious coronavirus particles found in hospital air add to mounting evidence of airborne transmission
The significant concentrations of virus found in hospital aerosols highlight the need to follow precautions like improved ventilation, experts said.
WHO says dentists have high risk of being infected by COVID-19, asks people to delay non essential dental work
WHO said that while dental services had begun, several procedures could be done in a way that minimised aerosol or micro-droplets hanging in the air.
Russia's 'Sputnik V' COVID-19 vaccine: WHO in close contact with Russian health ministry for 'rigorous review' of safety, efficacy data
When a vaccine is pre-qualified by the WHO, the manufacturers seek the agency's stamp of quality, and approval for its use.
As COVID-19 is a respiratory infection that affects the lungs, dysphagia is also common among the patients who were not ventilated.
Putin announces first 'registered' COVID-19 vaccine from Russia's Gamaleya Institute; his daughter among those inoculated
The Russian Health Minister has said that plans are in motion to start a mass vaccination campaign against the novel coronavirus in October.
With six vaccine candidates reaching Phase 3 trials, WHO's emergencies director Michael Ryan warned that a vaccine was "only part of the answer".
New Zealand crosses 100 days without any new domestic COVID-19 cases; WHO hails milestone as exemplary
The country halted the spread of SARS-CoV-2 by imposing a strict lockdown in late March when only around 100 people had tested positive.
WHO warns that vaccine hoggin nations won't be safe from COVID-19 if poor countries are still exposed
Tedros Ghebreyesus said, "For the world to recover faster, it has to recover together because it's a globalised world: the economies are intertwined."
The STFS virus is transmitted to humans by ticks or bits, and is thought to be fatal in 1 to 3 out of every 10 infections.
Evidence suggests younger children don’t spread the disease easily but kids aged 10 and up transmit as easily as adults.
Epidemiological studies will begin in Wuhan to identify the potential source of early cases of COVID-19, said WHO Director-General Tedros Adhanom Ghebreyesus
Post-COVID care: Take it easy on daily chores; try these techniques to manage fatigue, conserve energy
Given what we know about COVID-19 and the immense impact it has on patients’ lives, the road to recovery is expected to be more intense